Kirsten Flowers

This profile gathers the share dealings of Kirsten Flowers across 2 companies, led by Comera Life Sciences Holdings, Inc. and Kura Oncology, Inc. Over a trading history stretching from 26 January 2022 to 27 January 2023, the count stands at 4 filings.

On the open market, the record shows 1 purchase worth €16k and 1 sale worth €24k. On balance, insiders were net sellers of €8,542. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. 2023 to date brings 1 purchase and 1 sale.

The newest entry dates from 14 February 2023: an open-market purchase of €16k, in Comera Life Sciences Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.